Sign in
Taking people in United StatesNo phase

Diet and Exercise Advice for Prostate Cancer Survivors on Hormone Therapy

Tests diet and exercise advice in adults with prostate cancer on hormone therapy.

Key facts

Who runs it
Roswell Park Cancer Institute
Where
Buffalo, United StatesSee the site
Trial code
Registry title
Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer
Status
Recruiting
People taking part
50 people, planned
Started
2 May 2019
Expected to end
2 May 2029
Type of study
Interventional
Treatments tested
  • Dietary Intervention
  • Educational Intervention
  • Exercise Intervention
  • Quality-of-Life Assessment
  • Survey Administration
Record updated
7 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for men with prostate cancer who are on or about to start continuous androgen deprivation therapy (ADT). It tests nutrition and exercise advice to reduce obese frailty.

Age
18 years or older
Sex
Men only
Disease stage
Prostate adenocarcinoma confirmed by biopsy, of any stage or grade
Earlier treatment
Prescribed or already receiving continuous ADT for less than 5 years
Biomarker or test result
Hemoglobin above 11 g/dL; creatinine below 1.5 x upper limit of normal; liver function tests below 2 x upper limit of normal

Main reasons for not taking part

  • Severe chronic obstructive pulmonary disease (COPD), ischemic heart disease, congestive heart failure or significant heart rhythm problems
  • Orthopedic, musculoskeletal or psychological conditions that limit taking part (clinician decides)
  • Overall medical frailty (clinician decides)
  • Any condition that rules out extra blood collection
  • Unwilling or unable to follow the trial rules

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Biopsy-confirmed prostate adenocarcinoma of any stage/grade
  • Prescribed or already receiving continuous ADT for < 5 years
  • Hemoglobin > 11 g/dL
  • Creatinine < 1.5 x upper limit of normal (ULN), AST or ALT <2 x ULN within 6 months prior to enrollment
  • Liver function tests < 2 x ULN
  • Able to walk unassisted at least 100 meters (200 steps) or ECOG <= 1
  • No contraindications to any aspect of participation, including aerobic exercise
  • Participant must be able to read, write, and understand the English language and be able to provide written consent
  • Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure

Who cannot take part

  • Known clinically significant severe chronic obstructive pulmonary disease (COPD), ischemic heart disease, congestive heart failure, and/or significant cardiac arrhythmias
  • Limiting orthopedic, musculoskeletal or psychological conditions (clinician discretion)
  • Any condition contraindicating additional blood collection beyond standard of care
  • Any condition which in the investigator's opinion deems the participant an unsuitable candidate to receive study intervention
  • Overall medical frailty (clinician discretion)
  • Unwilling or unable to follow protocol requirements

Where in United States

  • Roswell Park Cancer InstituteBuffalo, United StatesContact: Ellis Levine, MDTaking people

About the trial

What the trial wants to find out

This trial studies how well nutrition and exercise interventions work in reducing androgen deprivation therapy-induced obese frailty in prostate cancer survivors. Individualized nutrition and exercise advice for prostate cancer patients on androgen deprivation therapy may help to reduce obese frailty and change the levels of myokines in blood.

The group in the trial

  • Supportive care (diet, exercise, education)Treatment being tested

    Patients receive an individualized diet plan for 6 months. Patients complete an individualized home-based exercise program aerobic and resistance exercise over 10-30 minutes per day, at minimum 3 days per week for 6 months, and a progressive resistance exercise program including an individually tailored prescription targeting the chest, shoulders, arms, and leg musculature for 1-4 sets of 10-15 repetitions, 5 days per week over 6 months. Patients also attend monthly educational meetings for 6 months.

    Treatment: Dietary Intervention, Educational Intervention, Exercise Intervention, Quality-of-Life Assessment, and Survey Administration

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer
Plain-language title
Diet and Exercise Advice for Prostate Cancer Survivors on Hormone TherapyGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
7 May 2026